EIKN Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

15.705

Open

15.475

VWAP

15.19

Vol

226.44K

Mkt Cap

908.19M

Low

14.670

Amount

3.44M

EV/EBITDA(TTM)

Total Shares

50.45M

EV/OCF(TTM)

P/S(TTM)

Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. It tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.

Events Timeline

(ET)

2026-02-05

16:50:00

Major Averages Broadly Lower as Investors Grow Cautious on Tech Stocks

2026-02-05

12:50:00

Eikon Therapeutics Prices 21.18M Shares at $18.00

2026-02-05

11:50:00

Eikon Therapeutics Prices 21.18M Shares at $18.00

2026-02-05

05:40:00

Deal Size Increased to 21.18M Shares, Priced at Top End of $16.00-$18.00 Range

News

7.0

11:47 AMBarron's

Amazon Takes Bold Steps in AI Investment, Posing Significant Risks for Markets.

8.5

00:23 AMBarron's

Liftoff Mobile Delays IPO Plans for the Time Being

8.5

02-05renaissancecapital

Eikon Therapeutics Raises $381 Million in Upsized IPO

0 Analyst Rating

Wall Street analysts forecast EIKN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EIKN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

No data

Valuation Metrics

The current forward P/E ratio for Eikon Therapeutics, Inc. (EIKN.O) is , compared to its 5-year average forward P/E of . For a more detailed relative valuation and DCF analysis to assess Eikon Therapeutics, Inc. 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

Current PE

NaN

Overvalued PE

Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

Current EV/EBITDA

NaN

Overvalued EV/EBITDA

Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

Current PS

NaN

Overvalued PS

Undervalued PS

Financials

AI Analysis

Annual

Quarterly

Whales Holding EIKN

Trading Trends

People Also Watch

Frequently Asked Questions

What is Eikon Therapeutics, Inc. (EIKN) stock price today?

The current price of EIKN is 15.2 USD — it has increased 1.33 % in the last trading day.

What is Eikon Therapeutics, Inc. (EIKN)'s business?

What is the price predicton of EIKN Stock?

Wall Street analysts forecast EIKN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EIKN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Eikon Therapeutics, Inc. (EIKN)'s revenue for the last quarter?

Eikon Therapeutics, Inc. revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is Eikon Therapeutics, Inc. (EIKN)'s earnings per share (EPS) for the last quarter?

Eikon Therapeutics, Inc.. EPS for the last quarter amounts to USD, decreased % YoY.

How many employees does Eikon Therapeutics, Inc. (EIKN). have?

Eikon Therapeutics, Inc. (EIKN) has 0 emplpoyees as of February 06 2026.

What is Eikon Therapeutics, Inc. (EIKN) market cap?

Today EIKN has the market capitalization of 908.19M USD.

EIKN Overview

EIKN Overview

Events Timeline

News

No data

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Whales Holding EIKN

Trading Trends

People Also Watch

Frequently Asked Questions

What is Eikon Therapeutics, Inc. (EIKN) stock price today?

What is Eikon Therapeutics, Inc. (EIKN)'s business?

What is the price predicton of EIKN Stock?

What is Eikon Therapeutics, Inc. (EIKN)'s revenue for the last quarter?

What is Eikon Therapeutics, Inc. (EIKN)'s earnings per share (EPS) for the last quarter?

How many employees does Eikon Therapeutics, Inc. (EIKN). have?

What is Eikon Therapeutics, Inc. (EIKN) market cap?